AvidBiotics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

AvidBiotics General Information

Description

Developer of novel non-antibody proteins designed to target bacteria virus-infected cells and cancers. The company generates non-antibody proteins that specifically target bacteria, viruses, or cancer cells for human therapeutic and prophylactic uses, as well as food safety, biodefense, animal husbandry, and a host of other potential applications, thereby enabling physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.

Contact Information

Website
www.avidbiotics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Kimball Way
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 100 Kimball Way
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AvidBiotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 01-Nov-2017 Completed Out of Business
8. Later Stage VC (Series E) 26-Aug-2014 Completed Generating Revenue
7. Grant 01-Jan-2013 Completed Generating Revenue
6. Later Stage VC (Series D) 27-Sep-2012 Completed Generating Revenue
5. Later Stage VC (Series C) 30-Aug-2012 Completed Generating Revenue
4. Grant 01-Sep-2010 Completed Generating Revenue
3. Early Stage VC (Series B) 11-Jan-2008 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Oct-2006 $1.85M $1.85M Completed Generating Revenue
1. University Spin-Out 01-Jan-2005 Completed Startup
To view AvidBiotics’s complete valuation and funding history, request access »

AvidBiotics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E
Series D
Series C
Series B 843,344 $0.001000 8% $1.35 $1.35 1x $1.35 5.56%
Series A 1,584,679 $0.001000 8% $1.17 $1.17 1x $1.17 10.44%
To view AvidBiotics’s complete cap table history, request access »

AvidBiotics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel non-antibody proteins designed to target bacteria virus-infected cells and cancers. The company gener
Biotechnology
South San Francisco, CA

Brisbane, CA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AvidBiotics Competitors (30)

One of AvidBiotics’s 30 competitors is Second Genome, a Formerly VC-backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Second Genome Formerly VC-backed Brisbane, CA
Eligo Bioscience Venture Capital-Backed Paris, France
BiomX Formerly VC-backed Ness Ziona, Israel
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
GangaGen Venture Capital-Backed Bangalore, India
You’re viewing 5 of 30 competitors. Get the full list »

AvidBiotics Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

AvidBiotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2903499-A1 Diffocins and methods of use thereof Inactive 14-Mar-2013
AU-2014240427-A1 Diffocins and methods of use thereof Inactive 14-Mar-2013
EP-2970401-A1 Diffocins and methods of use thereof Inactive 14-Mar-2013
EP-2658867-B1 Non-natural mic proteins Active 30-Dec-2010
EP-2658867-A1 Non-natural mic proteins Active 30-Dec-2010 C07K14/70539
To view AvidBiotics’s complete patent history, request access »

Ready to get started?

Request a free trial

AvidBiotics FAQs

  • When was AvidBiotics founded?

    AvidBiotics was founded in 2005.

  • Where is AvidBiotics headquartered?

    AvidBiotics is headquartered in South San Francisco, CA.

  • What industry is AvidBiotics in?

    AvidBiotics’s primary industry is Biotechnology.

  • Is AvidBiotics a private or public company?

    AvidBiotics is a Private company.

  • What is AvidBiotics’s current revenue?

    The current revenue for AvidBiotics is .

  • How much funding has AvidBiotics raised over time?

    AvidBiotics has raised $10.9M.

  • Who are AvidBiotics’s competitors?

    Second Genome, Eligo Bioscience, BiomX, Vedanta Biosciences, and GangaGen are some of the 30 competitors of AvidBiotics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »